The Fibrolamellar Registry is still looking for more participants to complete the Fibrolamellar Registry survey.
If you can help please click the link for more information.
https://t.co/BzZOEQp8vD
If you require assistance please PM the Registry FB.
#Fibrolamellar#livercancer
The #Fibrolamellar registry is still recruiting patients or caregivers to fill in the #Fibrolamellar survey.
https://t.co/BzZOEQp8vD
The survey is open to all Fibrolamellar patients. Please send us a PM if you need assistance.
#Opdivo#Keytruda#rarecancer
Meet the #JohnsHopkins oncologist we're helping with a new study of #immunecheckpointinhibitors and #fibrolamellar Looking at Opdivo (Nivolumab), Keytruda (Pembrolizumab), Imfinzi, Tecentriq, Yervoy, Bavencio and/or Tremelimumab. https://t.co/GiV69LNyRT
The Fibrolamellar Registry is still looking for patients and caregivers to fill in the #Fibrolamellar survey.Please click below for more information.https://t.co/BzZOEQp8vD
If you need assistance with the survey contact the Registry through the Facebook page.
#Opdivo#Keytruda
The Fibrolamellar Registry is currently reaching out to patients who have taken an Immune Checkpoint Inhibitor to take part in a patient survey.Please click the link for more information.
https://t.co/BzZOEQp8vD
#Fibrolamellar#livercancer#fibroregistry
If you or a family member has taken an Immune Checkpoint Inhibitor then please take a few moments to complete the #Fibrolamellar registry study. https://t.co/BzZOEQp8vD
#Opdivo#Keytruda#Livercancer
The Fibrolamellar Registry is still recruiting patients or caregivers who have taken an Immune Checkpoint Inhibitor.
You can learn more at https://t.co/BzZOEQp8vD
#fibrolamellar#livercancer#rarecancer#1in5million
We are still looking for patients & caregivers to fill in the survey on the Immune Checkpoint Inhibitor Study.
https://t.co/BzZOEQp8vD
#Fibrolamellar#Opdivo#Keytruda#Livercancer
Now would be a great time to fill in our survey. Please click the link below to find out more info on the Immune Checkpoint Inhibitor study.
https://t.co/BzZOEQp8vD
#fibrolamellar#LiverCancer#rarecancer
The Fibrolamellar Registry is helping recruit for a comprehensive survey of outcomes in #fibrolamellar patients who have taken immune checkpoint inhibitors. Please participate if you qualify. Learn more at https://t.co/BzZOEQp8vD #livercancer
https://t.co/cO0PySz5sA
Meet Luana, as she tells us about her beloved daughter Chiara's journey with fibrolamellar hepatocellular carcinoma. Luana makes an impassioned plea for everyone to contribute to https://t.co/lfUbQpS4E8. #fibrolamellar, #livercancer, #fibroregistry
Two research groups want to collaborate @FibroRegistry to study elevated ammonia in fibrolamellar patients. Please contact [email protected] if interested. We would like to help make this study as successful as possible!
Two research groups want to collaborate @FibroRegistry to study elevated ammonia in fibrolamellar patients. Please contact [email protected] if interested. We would like to help make this study as successful as possible!
Two research groups want to collaborate @FibroRegistry to study elevated ammonia in fibrolamellar patients. Please contact [email protected] if interested. We would like to help make this study as successful as possible!
Two research groups want to collaborate @FibroRegistry to study elevated ammonia in fibrolamellar patients. Please contact [email protected] if interested. We would like to help make this study as successful as possible!
Two research groups want to collaborate @FibroRegistry to study elevated ammonia in fibrolamellar patients. Please contact [email protected] if interested. We would like to help make this study as successful as possible!